StockData
Gossamer Bio, Inc. logo

Gossamer Bio, Inc. (GOSS) stock

GOSSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$11.04+0.06 (+0.55%)

Close on Nov 17, 2026Market cap $5.40BP/E –Yield –

Gossamer Bio price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Gossamer Bio's price to sales ratio was 1.3× on Nov 11, 2026, against 17.5× a year earlier. Over the last 2 years it ranged from 0.7× to 17.5×, with a median of 2.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.3×−14.9
2025Dec 31, 202516.3×+14.3
2024Dec 31, 20241.9×–

More Gossamer Bio figures

See a number that looks wrong?